Noradrenaline in Alzheimer’s Disease: A New Potential Therapeutic Target

A growing body of evidence demonstrates the important role of the noradrenergic system in the pathogenesis of many neurodegenerative processes, especially Alzheimer’s disease, due to its ability to control glial activation and chemokine production resulting in anti-inflammatory and neuroprotective e...

Descripción completa

Detalles Bibliográficos
Autores principales: Gutiérrez, Irene L., Dello Russo, Cinzia, Novellino, Fabiana, Caso, Javier R., García-Bueno, Borja, Leza, Juan C., Madrigal, José L. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181823/
https://www.ncbi.nlm.nih.gov/pubmed/35682822
http://dx.doi.org/10.3390/ijms23116143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181823/
https://www.ncbi.nlm.nih.gov/pubmed/35682822
http://dx.doi.org/10.3390/ijms23116143

Ejemplares similares